Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xia Shi

Showing results (511-520 of 518) with videos related to

Pageof 52
Sort By:
You have reached the last page of results.This site can display upto 518 results.
Asian Pacific Journal of Cancer Prevention : APJCP|February 28, 2022
Perceived Importance of Breast Cancer Risk Factors: A Survey on 386 Physicians in ChinaLouis Wing-Cheong Chow, Pei-Fen Fu, Lei Guo, et al.
Trials|January 8, 2021
Acupuncture for persistent atrial fibrillation after catheter ablation: study protocol for a pilot randomized controlled trialYing Lin, Xian Wang, Xue-Bin Li, et al.
Nature|March 29, 2020
Identifying SARS-CoV-2-related coronaviruses in Malayan pangolinsTommy Tsan-Yuk Lam, Na Jia, Ya-Wei Zhang, et al.
Circulation|February 6, 2026
Apolipoprotein D, a Novel Ligand for CD36, Is Essential for Blood-Brain Barrier IntegrityChang-Xiong Gong, Pei-Xia Shi, Yan-Jie Huang, et al.
JAMA|December 10, 2020
Effect of Capecitabine Maintenance Therapy Using Lower Dosage and Higher Frequency vs Observation on Disease-Free Survival Among Patients With Early-Stage Triple-Negative Breast Cancer Who Had Received Standard Treatment: The SYSUCC-001 Randomized Clinical TrialXi Wang, Shu-Sen Wang, Heng Huang, et al.
Cancer Cell|April 11, 2025
Neoadjuvant toripalimab plus nimotuzumab combined with taxol-based chemotherapy in locally advanced penile squamous cell carcinomaXin An, Sheng Jie Guo, Ru Yan, et al.
Lancet (London, England)|June 10, 2021
Metronomic capecitabine as adjuvant therapy in locoregionally advanced nasopharyngeal carcinoma: a multicentre, open-label, parallel-group, randomised, controlled, phase 3 trialYu-Pei Chen, Xu Liu, Qin Zhou, et al.
Breast Cancer (Dove Medical Press)|April 17, 2024
Does the Dose of Standard Adjuvant Chemotherapy Affect the Triple-negative Breast Cancer Benefit from Extended Capecitabine Metronomic Therapy? An Exploratory Analysis of the SYSUCC-001 TrialYing Chen, Wen-Xia Li, Jia-Hua Wu, et al.
Pageof 52

Showing results (511-520 of 518) with videos related to

Sort By:
Pageof 52
You have reached the last page of results.This site can display upto 518 results.
Asian Pacific Journal of Cancer Prevention : APJCP|February 28, 2022
Perceived Importance of Breast Cancer Risk Factors: A Survey on 386 Physicians in ChinaLouis Wing-Cheong Chow, Pei-Fen Fu, Lei Guo, et al.
Trials|January 8, 2021
Acupuncture for persistent atrial fibrillation after catheter ablation: study protocol for a pilot randomized controlled trialYing Lin, Xian Wang, Xue-Bin Li, et al.
Nature|March 29, 2020
Identifying SARS-CoV-2-related coronaviruses in Malayan pangolinsTommy Tsan-Yuk Lam, Na Jia, Ya-Wei Zhang, et al.
Circulation|February 6, 2026
Apolipoprotein D, a Novel Ligand for CD36, Is Essential for Blood-Brain Barrier IntegrityChang-Xiong Gong, Pei-Xia Shi, Yan-Jie Huang, et al.
JAMA|December 10, 2020
Effect of Capecitabine Maintenance Therapy Using Lower Dosage and Higher Frequency vs Observation on Disease-Free Survival Among Patients With Early-Stage Triple-Negative Breast Cancer Who Had Received Standard Treatment: The SYSUCC-001 Randomized Clinical TrialXi Wang, Shu-Sen Wang, Heng Huang, et al.
Cancer Cell|April 11, 2025
Neoadjuvant toripalimab plus nimotuzumab combined with taxol-based chemotherapy in locally advanced penile squamous cell carcinomaXin An, Sheng Jie Guo, Ru Yan, et al.
Lancet (London, England)|June 10, 2021
Metronomic capecitabine as adjuvant therapy in locoregionally advanced nasopharyngeal carcinoma: a multicentre, open-label, parallel-group, randomised, controlled, phase 3 trialYu-Pei Chen, Xu Liu, Qin Zhou, et al.
Breast Cancer (Dove Medical Press)|April 17, 2024
Does the Dose of Standard Adjuvant Chemotherapy Affect the Triple-negative Breast Cancer Benefit from Extended Capecitabine Metronomic Therapy? An Exploratory Analysis of the SYSUCC-001 TrialYing Chen, Wen-Xia Li, Jia-Hua Wu, et al.
Pageof 52